Hindustan Times (Amritsar)

2 firms, Guj institute to scale up jab production

- Anonna Dutt letters@hindustant­imes.com

NEW DELHI: To ramp up the manufactur­ing of Covaxin, Bharat Biotech will transfer technology to two Ahmedabad-based companies and a state-run biotechnol­ogy research institute in Gandhinaga­r. A statement to this effect released by the department of biotechnol­ogy (under the Union ministry of science & technology) on Saturday informed that “technology transfer agreements have been finalised with all manufactur­ers”.

Two of the manufactur­ers are Hester Bioscience­s, an animal healthcare company, and OmniBRx, a biotech company. The third, Gujarat Biotechnol­ogy Research Centre, is an institute under the state’s department of science and technology. Together, they are likely to add a production capacity of 20 million doses per month.

The Centre had last month announced financial support to Bharat Biotech as well as three public sector undertakin­gs to increase vaccine production to 100 million doses per month by September. A grant of ₹65 crore was given to Biotech’s new Bengaluru facility to repurpose it for vaccine production. Another ₹65 crore was given to PSU Haffkine Biopharmac­eutical Corporatio­n in Mumbai to manufactur­e 20 million doses a month, ₹60 crore to Indian Immunologi­cals Limited-Hyderabad, and ₹30 crore to Bharat Immunologi­cals and Biological­s Limited in Bulandshah­r for 15 million doses a month.

Last week, top government advisor, Dr VK Paul of Niti Aayog, said that the Centre and Bharat Biotech are willing to invite other companies to produce the vaccine. This was amid growing calls from experts to transfer the technology of the indigenous­ly developed vaccine, the rights to which are jointly owned by Indian Council of Medical Research.

But Paul insisted that Saturday’s announceme­nt wasn’t influenced by the growing clamour for technology transfer even though some people have tried to make that connection. “Complex technologi­es cannot be transferre­d like this. It takes about 70 to 75 days for the vaccine to be manufactur­ed. Bharat Biotech along with the government have transferre­d technology to the three PSUs,” Paul said.

Newspapers in English

Newspapers from India